Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950103-24-013848
Filing Date
2024-09-23
Accepted
2024-09-23 16:35:12
Documents
6
Period of Report
2024-11-11

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A dp218056_def14a.htm DEF 14A 116871
2 GRAPHIC image_001.jpg GRAPHIC 4159
3 GRAPHIC image_002.jpg GRAPHIC 198250
4 GRAPHIC image_003.jpg GRAPHIC 205166
5 GRAPHIC image_004.jpg GRAPHIC 144133
6 GRAPHIC image_005.jpg GRAPHIC 395160
  Complete submission text file 0000950103-24-013848.txt   1422542
Mailing Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066
Business Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066 41 21 653 02 00
ADC Therapeutics SA (Filer) CIK: 0001771910 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39071 | Film No.: 241316614
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)